CLINICAL TRIALS PROFILE FOR ENTECAVIR
✉ Email this page to a colleague
All Clinical Trials for ENTECAVIR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00035633 ↗ | A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen | Completed | Bristol-Myers Squibb | Phase 3 | 2001-12-01 | The purpose of this clinical research study is to assess the safety effectiveness of entecavir, as compared to lamivudine, in the treatment of adults with chronic hepatitis B infection who are hepatitis B e antigen positive. |
NCT00035789 ↗ | A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen | Completed | Bristol-Myers Squibb | Phase 3 | 2001-11-01 | The purpose of this clinical research study is to assess the safety and effectiveness of entecavir, as compared to lamivudine, in the treatment of adults with chronic hepatitis B infection who are hepatitis B e antigen negative. |
NCT00036608 ↗ | A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine | Completed | Bristol-Myers Squibb | Phase 3 | 2002-01-01 | The purpose of this clinical research study is to assess the safety and effectiveness of switching to entecavir compared to continued lamivudine in patients with chronic hepatitis B. |
NCT00051038 ↗ | Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients | Completed | Bristol-Myers Squibb | Phase 2/Phase 3 | 2002-09-01 | The purpose of this clinical research study is to assess the safety and effectiveness of entecavir, when being added to lamivudine, in the treatment of adults with chronic hepatitis B infection who are co-infected with HIV. |
NCT00065507 ↗ | Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation | Completed | Bristol-Myers Squibb | Phase 3 | 2003-08-01 | This is a phase IIIb comparative study of entecavir 1.0 mg once daily (QD) vs. adefovir 10 mg QD in patients who have chronic hepatitis B infection and hepatic decompensation. The patients are treated for 96 weeks after the last subject is randomized. |
NCT00096785 ↗ | Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection | Completed | Bristol-Myers Squibb | Phase 3 | 2004-12-01 | The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine. |
NCT00096811 ↗ | Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program | No longer available | Bristol-Myers Squibb | 2003-09-01 | The purpose of this clinical research study is to provide entecavir to subjects with chronic Hepatitis B infection who have failed or who have demonstrated intolerance of marketed therapies or for those in whom use of these agents is contraindicated and that have no other available treatment options. | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ENTECAVIR
Condition Name
Clinical Trial Locations for ENTECAVIR
Trials by Country
Clinical Trial Progress for ENTECAVIR
Clinical Trial Phase
Clinical Trial Sponsors for ENTECAVIR
Sponsor Name